Spasenija Savic, UPDATED CAP/IASLC/ UPDATES,...
Transcript of Spasenija Savic, UPDATED CAP/IASLC/ UPDATES,...
12.00-12.30UPDATED CAP/IASLC/AMP MOLECULAR TESTINGGUIDELINES FOR THESELECTION OF LUNG CANCERPATIENTS FOR TREATMENTWITH TARGETED TYROSINEKINASE INHIBITORS:UPDATES, MODIFICATIONS,AND IMPLICATIONS FORCYTOLOGY SPECIMENSPaul VanderLaan, MD, PhD,Department of Pathology, BethIsrael Deaconess Medical Center,Boston, Massachusetts, USA
12.30-13.30 LUNCH
VII SESSIONUPDATES IN MODERNCYTOPATHOLOGY (II)
ChairsPietro Micheli, MD, Ospedaledei Colli, Naples, ItalyRoberto Bianco, MD, PhDUniversity of Naples Federico II,Italy
13.30-14.00LIQUID BIOPSY:STATE OF ARTUmberto Malapelle, PhD,University of Naples Federico II,Italy
14.00-14.30DETECTION OF ALK ANDROS1 POSITIVE NSCLC BYIMMUNOCYTOCHEMISTRY ONCONVENTIONAL CYTOLOGY
Spasenija Savic, MD, UniversityHospital Basel, Switzerland
14.30-15.00APPLICATION OF NANOSTRING TECHNOLOGY ON CYTOLOGICAL SPECIMENRossella Bruno, MD, University of Pisa School of Medicine, Pisa, Italy
15.00-15.30SALVAGING THE SUPERNATANT:NEXT GENERATIONCYTOPATHOLOGY FOR SOLIDTUMOR MUTATION PROFILINGSinchita Roy-Chowdhuri, MD,PhD, MD Anderson Cancer Center,Houston, TX, USA
15.30-16.00PD-L1 TESTING: ISSUES FROMROUTINE PRACTICEElena Vigliar, MD, PhD, Universityof Naples Federico II, Italy
16.00-16.30BEYOND PD-L1 TESTINGMaría D. Lozano Escario, MD, Phd,University of Navarra Clinic,Pamplona, Spain
16.30-17.00TAKE HOME-MESSAGESGiancarlo Troncone, MD, PhD,University of Naples Federico II, Italy
con il patrocinio di
26-27 November 2018Naples, Italy Centro Congressi Federico IIVia Partenope, 36 Napoli
Meeting Director Giancarlo Troncone
Honorary PresidentsLucio PalombiniAntonio VetraniDipartimento di Sanità PubblicaDirettore Maria Triassi
Università degli Studi di Napoli Federico II
Segreteria scientificaClaudio Bellevicine, Umberto Malapelle,Elena Vigliar
concerto srlCalata San Marco, 13 80133 Napolitel. +39 081 19569195 fax +39 081 [email protected] www.concertosrl.net
Obiettivo formativoContenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica. Malattie rare.
Evento ECM n. 700- 229869 ed. 112 crediti formativi ECM per:Medico Chirurgo (genetica medica; oncologia;anatomia patologica; biochimica clinica; endocrinologia;malattie metaboliche e diabetologia; medicina interna;chirurgia generale; chirurgia toracica; radiodiagnostica; radioterapia; ginecologia e ostetricia; urologia; anestesia e rianimazione; laboratorio di genetica medica),Biologo, Tecnico Sanitario Laboratorio Biomedico
Ai fini dell’attribuzione dei crediti ECM, è necessario procedere alla compilazione dei questionari di verifica e valutazione esclusiva-mente in modalità ONLINE.Il questionario sarà disponibile sulla piattaforma dalla conclu-sione del congresso e a disposizione dei partecipante della ricezione della mail.Resterà attivo per soli 3 giorni e sarà possibile effettuare un solo tentativo per la compilazione.
Quota di partecipazione:Euro 50,00 + IVA 22% (€ 61,00 )La quota d’iscrizione da diritto alla partecipazione ai lavori, ai coffe break, ai lunch, all’attestato di partecipazione e ai crediti ECM per gli aventi diritto.
È prevista traduzione simultanea dall’inglese.
Segreteria Organizzativa e Provider ECM
Amgen Arrow Diagnostics AstraZeneca BiocartisBoehringer-Ingelheim ItaliaHologic Italia Leica Biosystems
Merck Serono MSD ItaliaPfizer RocheSialThermoFisher
Si ringraziano:
26 NOVEMBER
9.30WelcomeMaria TriassiDirettore Dipartimento SanitàPubblicaMauro TruiniPresidente SIAPEC-IAPGaetano De RosaPast President SIAPEC-IAPLucio PalombiniProfessore EmeritoGiancarlo TronconeMeeting Director
10.00-10.30OPENING LECTURELucio Palombini MD, Universityof Naples Federico II, Italy
I SESSIONCLASSIFICATION INCYTOPATHOLOGY (I)ChairsEsther Diana Rossi, MD, CatholicUniversity of Rome, ItalyStefania Staibano, MD, PhDUniversity of Naples Federico II,Italy
10.30-11.00WHY DO YOU NEED TOGIVE NAMES?Fernando Schmitt, MD, PhD, FIAC, Porto University and IPATIMUP, Porto, Portugal
11.00-11.30THE MILAN SYSTEM FORREPORTING SALIVARY GLANDCYTOPATHOLOGYPhilippe Vielh, MD, PhD, FIAC,Laboratoire National de Santé,Dudelange, Luxembourg
11.30-12.00 COFFEE BREAK
II SESSIONCLASSIFICATION INCYTOPATHOLOGY (II)ChairsGerardo Botti, MD, IstitutoPascale, Napoli, ItalyPio Zeppa, MD, PhD, Universityof Salerno, Italy
12.00-12.30THE PARIS SYSTEMFOR REPORTING URINARYTRACT CYTOLOGYAshish Chandra, MD, FRCPath,DipRCPath, Guy’s and St. Thomas Hospital NHS, Foundation Trust, London
12.30-13.00THE YOKOHAMA SYSTEMFOR REPORTING DIRECTLYSAMPLED ENDOMETRIALCYTOLOGY: THE QUEST TODEVELOP A STANDARDIZEDTERMINOLOGYFranco Fulciniti, MD, PhD,Clinical Cytopathology Service,Istituto Cantonale di Patologia,Locarno Switzerland
13.00-14.00 LUNCH
III SESSIONCLASSIFICATION INCYTOPATHOLOGY (III):FOCUS ON THYROIDChairsGuido Fadda, MD, CatholicUniversity of Rome, Italy
14.00-14.30THYROID FNA: NEWCLASSIFICATIONS AND NEWINTERPRETATIONSBeatrix Cochand-Priollet, MD,PhD, Department of Pathology,Cochin Hospital, University Paris-Descartes, Paris, France
14.30-15.00PERFORMANCE QUALITYMEASURES IN THYROIDCYTOPATHOLOGY: ARE WEGOOD IN APPLYING BETHESDACRITERIA?Paul VanderLaan, MD, PhD,Department of Pathology, BethIsrael Deaconess Medical Center,Boston, Massachusetts, USA
15.00-15.30MOLECULAR PATHOLOGYOF THYROID TUMOURS OFFOLLICULAR CELLS:GENETIC ALTERATIONS ANDTHEIR CLINICOPATHOLOGICALRELEVANCEGiovanni Tallini, MD,University of Bologna, Italy
15.30-16.00 COFFEE BREAK
IV SESSIONTHYROID MOLECULARCYTOPATHOLOGY:AN ITALIAN EXPERIENCEChairsGiancarlo Troncone, MD,PhD, University of NaplesFederico II, ItalyAnnamaria Colao, MD,PhD University of NaplesFederico II, Italy
16.00-16.30THE TIRNET PROJECTClaudio Bellevicine, MD, PhD,University of Naples Federico II,Italy
TIRNET Group InteractiveDiscussion
16.30-17.30THE BETHESDA SYSTEMFOR REPORTING THYROIDCYTOPATHOLOGY EXPLAINED.FREQUENTLY ASKEDQUESTIONS FROMNON-PATHOLOGISTMassimo Bongiovanni, MD,University Institute of Pathology,UNIL-CHUV, Lausanne, SwitzerlandClaudio Bellevicine, MD, PhD,University of Naples Federico II,Italy
THE TIRNET Group DiscussantL. Barba, G. Bellastella, B. Biondi,M. Cacciapuoti, A. Caleo,S. Campione, M. G. Chiofalo,G. Ciancia, G. Conzo, I. Cozzolino,M. D’ Anna, R. D’Anna, G. De Chiara, G. De Dominicis, N. De Rosa, S. Di Martino, F. Di Gennaro, G. Docimo,F. Fonderico, D. Gerbasio, R. Giannattasio, G. Iannaci, E. M. Iervolino, S. Iorio,F. La Vecchia, C. A. Leone,F. Lo Calzo, N.S. Losito, G. Lupoli,V. Marotta, M. Mascolo, S. Masone,R. Monaco, V. Novizio, V. Nuzzo,L. Pezzullo, C. Peirce, G. Pontieri,D. Salvatore, F. Scavuzzo,D. Serino, A. A. Sinisi,S. Spiezia, E. Vigliar, P. Zeppa
18.00CLOSING REMARKSGiancarlo Troncone, MD, PhD,University of Naples Federico II,Italy
27 NOVEMBER
10.00V SESSIONUPDATES IN MODERNCYTOPATHOLOGY (I)ChairsPhilippe Vielh, MD, PhD, FIAC,Laboratoire National de Santé,Dudelange, LuxembourgFiamma Buttitta, MD, PhD,University of Chieti, Italy
10.00-10.30ROADMAP TOWARD THEDEVELOPMENT OF A NETWORKOF ITALIAN LABORATORIESPERFORMING NEXTGENERATION SEQUENCINGAntonio Marchetti, MD, PhD,University of Chieti, Italy
10.30-11.00ISSUES IN MOLECULARCYTOPATHOLOGY:AN OVERVIEWGiancarlo Troncone, MD, PhDUniversity of Naples Federico II,Italy
11.00-11.30 COFFEE BREAK
VI SESSIONGUIDELINES UPDATES INMODERN CYTOPATHOLOGYChairsGiancarlo Troncone, MD, PhD,University of Naples Federico II, ItalyGiovanni Tallini, MD, University ofBologna, Italy
11.30-12.00COLLECTION AND HANDLINGOF THORACIC SMALL BIOPSYAND CYTOLOGY SPECIMENSFOR ANCILLARY STUDIES:GUIDELINE FROM THE COLLEGEOF AMERICAN PATHOLOGISTSSinchita Roy-Chowdhuri, MD,PhD, MD Anderson Cancer Center,Houston, TX, USA